DrugCite
Search

HEXABRIX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Hexabrix Adverse Events Reported to the FDA Over Time

How are Hexabrix adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Hexabrix, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Hexabrix is flagged as the suspect drug causing the adverse event.

Most Common Hexabrix Adverse Events Reported to the FDA

What are the most common Hexabrix adverse events reported to the FDA?

Anaphylactic Shock
38 (4.29%)
Hypotension
31 (3.5%)
Erythema
21 (2.37%)
Hypersensitivity
18 (2.03%)
Nausea
18 (2.03%)
Pruritus
18 (2.03%)
Bradycardia
17 (1.92%)
Off Label Use
17 (1.92%)
Loss Of Consciousness
16 (1.81%)
Malaise
14 (1.58%)
Dyspnoea
13 (1.47%)
Show More Show More
Face Oedema
13 (1.47%)
Hyperthermia
13 (1.47%)
Shock
13 (1.47%)
Vomiting
13 (1.47%)
Blood Pressure Decreased
12 (1.36%)
Myoclonus
12 (1.36%)
Rash
11 (1.24%)
Somnolence
11 (1.24%)
Paraesthesia
10 (1.13%)
Angioedema
9 (1.02%)
Bronchospasm
9 (1.02%)
Chills
9 (1.02%)
Drug Administration Error
9 (1.02%)
Urticaria
9 (1.02%)
Cough
8 (.9%)
Oxygen Saturation Decreased
8 (.9%)
Status Epilepticus
8 (.9%)
Cardio-respiratory Arrest
7 (.79%)
Feeling Hot
7 (.79%)
Sneezing
7 (.79%)
Tachycardia
7 (.79%)
Cold Sweat
6 (.68%)
Convulsion
6 (.68%)
Dermatitis Bullous
6 (.68%)
Leukopenia
6 (.68%)
Pyrexia
6 (.68%)
Synovitis
6 (.68%)
Anaphylactic Reaction
5 (.56%)
Coma
5 (.56%)
Condition Aggravated
5 (.56%)
Cyanosis
5 (.56%)
Generalised Erythema
5 (.56%)
Rash Vesicular
5 (.56%)
Renal Failure
5 (.56%)
Wrong Drug Administered
5 (.56%)
Anuria
4 (.45%)
Arteriospasm Coronary
4 (.45%)
Atrial Fibrillation
4 (.45%)
Atrioventricular Block
4 (.45%)
C-reactive Protein Increased
4 (.45%)
Chest Pain
4 (.45%)
Dermatitis Exfoliative
4 (.45%)
Eyelid Oedema
4 (.45%)
Formication
4 (.45%)
Ischaemia
4 (.45%)
Laryngeal Dyspnoea
4 (.45%)
Livedo Reticularis
4 (.45%)
Platelet Count Decreased
4 (.45%)
Rash Pustular
4 (.45%)
Renal Failure Chronic
4 (.45%)
Septic Shock
4 (.45%)
Torsade De Pointes
4 (.45%)
Tremor
4 (.45%)
Abdominal Distension
3 (.34%)
Abdominal Pain
3 (.34%)
Arthralgia
3 (.34%)
Back Pain
3 (.34%)
Bronchospasm Paradoxical
3 (.34%)
Cardiogenic Shock
3 (.34%)
Circulatory Collapse
3 (.34%)
Confusional State
3 (.34%)
Drug Hypersensitivity
3 (.34%)
Drug Interaction
3 (.34%)
Drug Rash With Eosinophilia And Sys...
3 (.34%)
Electrocardiogram Qt Prolonged
3 (.34%)
Electrocardiogram St Segment Elevat...
3 (.34%)
Eye Pain
3 (.34%)
Flushing
3 (.34%)
Headache
3 (.34%)
Hypertension
3 (.34%)
Hypoxia
3 (.34%)
Incorrect Route Of Drug Administrat...
3 (.34%)
Lacrimation Increased
3 (.34%)
Muscular Weakness
3 (.34%)
Oropharyngeal Discomfort
3 (.34%)
Pelvic Pain
3 (.34%)
Post Procedural Complication
3 (.34%)
Procedural Complication
3 (.34%)
Rash Rubelliform
3 (.34%)
Respiratory Arrest
3 (.34%)
Respiratory Distress
3 (.34%)
Rhinitis
3 (.34%)
Sensation Of Heaviness
3 (.34%)
Ventricular Tachycardia
3 (.34%)
Abdominal Pain Upper
2 (.23%)
Acute Pulmonary Oedema
2 (.23%)
Altered State Of Consciousness
2 (.23%)
Anaemia
2 (.23%)
Angle Closure Glaucoma
2 (.23%)
Aphasia
2 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Hexabrix, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Hexabrix is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Hexabrix

What are the most common Hexabrix adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Hexabrix, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Hexabrix is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Hexabrix According to Those Reporting Adverse Events

Why are people taking Hexabrix, according to those reporting adverse events to the FDA?

Arteriogram Coronary
46
Arthrogram
29
Angiogram
25
Spinal Myelogram
19
Catheterisation Cardiac
15
Angiogram Cerebral
10
Show More Show More
Product Used For Unknown Indication
8
Arteriogram
6
Hysterosalpingogram
6
Cardiovascular Evaluation
6
Cardiac Ventriculogram
3
Stent Placement
3
Coronary Angioplasty
3
Endoscopic Retrograde Cholangiopanc...
3
Drug Use For Unknown Indication
2
Catheterisation Cardiac Abnormal
2
Ill-defined Disorder
2
Fistulogram
2
Arteriogram Renal
1
Cardiac Monitoring
1
Scan With Contrast
1
Abdomen Scan
1
Scan
1
Cholangiogram
1
Central Venous Catheterisation
1

Drug Labels

LabelLabelerEffective
Hexabrix Guerbet LLC02-DEC-10

Hexabrix Case Reports

What Hexabrix safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Hexabrix. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Hexabrix.